---
title: "Weight loss new drug falls short of expectations, Novo Nordisk plummets nearly 30% in pre-market! Competitor Eli Lilly surges over 10%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/222920984.md"
description: "Novo Nordisk stated on Friday that its next-generation obesity drug Cagrisema achieved only a 22.7% weight loss in a trial, below its expected 25%"
datetime: "2024-12-20T11:07:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/222920984.md)
  - [en](https://longbridge.com/en/news/222920984.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/222920984.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/222920984.md) | [繁體中文](https://longbridge.com/zh-HK/news/222920984.md)


# Weight loss new drug falls short of expectations, Novo Nordisk plummets nearly 30% in pre-market! Competitor Eli Lilly surges over 10%

A highly anticipated study shows that a dual-drug combination called CagriSema helped people lose an average of 22.7% of their weight after more than a year of weekly injections, while patients receiving a placebo lost 2.3%.

Novo Nordisk stated on Friday that its experimental next-generation obesity drug CagriSema helped overweight patients lose 22.7% of their weight in a late-stage trial, falling short of its expected 25%, leading to a significant drop in its stock price.

Meanwhile, competitor Eli Lilly surged over 9% in pre-market trading after Novo Nordisk released the clinical data for CagriSema, which showed that patients lost 22.7% of their weight in the trial, below previous expectations

### 相关股票

- [Novo Nordisk AS (NVO.US)](https://longbridge.com/zh-CN/quote/NVO.US.md)
- [Eli Lilly (LLY.US)](https://longbridge.com/zh-CN/quote/LLY.US.md)

## 相关资讯与研究

- [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/zh-CN/news/281323250.md)
- [Novo Nordisk's Wegovy Weekly Injection Recommended by UK for Obese Cardiovascular Patients](https://longbridge.com/zh-CN/news/281331550.md)
- [Novo Nordisk Launches Discounted Subscription Program for Wegovy Obesity Drugs -- Update](https://longbridge.com/zh-CN/news/281201382.md)
- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/zh-CN/news/281206892.md)
- [U.K. Healthcare System to Offer Novo Nordisk's Wegovy Shot to 1.2 Million Heart Patients](https://longbridge.com/zh-CN/news/281325320.md)